Julian Tompkins, President of Ashfield Commercial and Patient Solutions has contributed to a new eyeforpharma white paper alongside thought leaders from Pfizer, AstraZeneca, Leo, McKinsey and more.
The rise of digital and patient-led medicine, the waning of many blockbuster medicines, more niche treatments and a keener search for value from payers are just some of the factors driving leading pharma marketeers to establish leaner and more responsive approaches to marketing.
In this whitepaper, you will learn:
- Why agility is the future of pharma marketing
- How companies embraced agility to great success
- How a ‘design thinking’ approach has been implemented
- The importance of metrics and how to measure agility